Pfizer to add Wyeth directors to board

A regulatory filing made yesterday reveals more juicy details about the Pfizer-Wyeth deal: Pfizer will add two Wyeth directors to its board, the Associated Press reports, and if Wyeth backs out of the deal, it would have to pay a breakup fee of up to $2 billion. As you know, Pfizer's breakup fee is more than double that, at $4.5 billion. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.